Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase 2 Study of Pevonedistat (P) Plus Azacitidine (A) Versus Azacitidine in Patients (pts) with Higher-Risk Myelodysplastic Syndromes (mds)/chronic Myelomonocytic Leukemia (CMML) or Low-Blast Acute Myelogenous Leukemia (LB-AML) (NCT02610777)

ONCOLOGY RESEARCH AND TREATMENT(2020)

Cited 2|Views8
No score
Key words
pevonedistat,azacitidine,myelodysplastic syndromes,MDS,chronic myelomonocytic leukemia,acute myeloid leukemia,AML
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined